Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. PharmaLogic CSP, Inc.
483
•PharmaLogic CSP, Inc.•December 12, 2014

PharmaLogic CSP, Inc. – FDA 483, Dec 12, 2014

Record Details

During an inspection conducted from December 8-12, 2014, the FDA observed significant deficiencies at PharmaLogic CSP, Inc., an outsourcing facility. The inspection, guided by current Good Manufacturing Practices and specific requirements for 503B facilities, revealed several critical issues. Key observations included inadequate systems for cleaning and disinfecting aseptic processing areas, such as the absence of sporicidal agents and improper cleaning of critical equipment. Environmental monitoring was found to be deficient, lacking written procedures, specific sampling frequencies, and alert limits, with no personnel monitoring during routine production. The facility also failed to properly maintain equipment controlling aseptic conditions, evidenced by undocumented pressure differential reviews and no continuous monitoring. Furthermore, procedures designed to prevent microbiological contamination were not consistently followed during process validations, with incomplete documentation for media fills and a lack of proper controls. The firm did not use stability testing results to establish expiration dates for sterile drug products, and critical components like containers and closures were used without proper quality control release or Certificates of Analysis. Finally, several drug product labels lacked required information for outsourcing facilities, such as "This is a compounded drug," "Office Use Only," compounding date, and administration details. The company is expected to address these observations by implementing comprehensive corrective and preventive actions to ensure regulatory compliance.

Company
PharmaLogic CSP, Inc.
Inspection date
December 12, 2014
Product type
Drugs
Office
Baltimore District Office
People
  • Rachel C. Harrington (Senior Advisor)
  • Doan T. Nguyen (Microbiologist )
  • Mujadala M. Abdul-Majid (Strategy Counsel)
View Company Profile

ID · d12072d9-8d38-485e-8fb7-056cadc9c111

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore PharmaLogic CSP, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.